- Presentations
- 2
- Markets
- 1
Doxorubicin Hydrochloride Liposome is a brand of Doxorubicin marketed by Sagent Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Doxorubicin
- Brand owner
- Sagent Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 20 mg/10 mL liposomal injectable suspension, 50 mg/25 mL liposomal injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Doxorubicin Hydrochloride Liposome 20 mg/10 mL liposomal injectable suspensionIntravenous Cold chain | Sagent Pharmaceuticals | US FDA | Available on request |
| Doxorubicin Hydrochloride Liposome 50 mg/25 mL liposomal injectable suspensionIntravenous Cold chain | Sagent Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Doxorubicin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Doxorubicin Hydrochloride Liposome
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.